Mark Tomaino is an Operating Partner at Welsh, Carson, Anderson & Stowe, a New York City based private equity firm that invests, principally, in two markets, healthcare and information/business services. Mark’s focus is exclusively on healthcare technology investment opportunities, including deal generation, due diligence, execution and portfolio company monitoring. Mark has served on the board of directors of Matrix Medical Network and GetWellNetwork.
Prior to September 2010, Mark served as Senior Vice President, Corporate Development and M&A at The TriZetto Group, a leading healthcare information technology company to the healthcare payer industry, where he had responsibility for developing and executing its external growth strategies, including mergers and acquisitions, strategic alliances, joint ventures, investments and capital raising activities. Mark initiated the $1.4 billion go-private transaction with Apax Partners in August 2008 ending TriZetto’s tenure as a NASDAQ-listed public company. Prior to joining TriZetto, Mark worked at Bausch & Lomb Incorporated in a variety of legal, strategy and business development capacities.
Mark holds an M.B.A. from The Paul Merage School of Business, University of California, Irvine, where he was Valedictorian and a member of the Beta Gamma Sigma Society, a J.D. from the Albany Law School of Union University, where he was a member of the Law Review, and an A.B. in English and Economics from the College of the Holy Cross.
0:00 The inside scoop of the J.P. Morgan Conference.
01:30 “What does Trump mean to the Healthcare Markets, and Investment Opportunities?”
02:00 “Where there’s uncertainty, there’s risk and volatility.”
03:15 Risk-Adjusted Rates of Return.
04:00 The risk-free aspects of Healthcare.
04:20 The High-risk aspects of Healthcare right now.
05:25 “Ultimately more competition means lower pricing.”
08:00 Investments and Episodic Care Claims.
10:20 Relying on the skills of a Venture Capitalist.
11:00 Looking at Demand-Drivers.
13:15 “The reality is we all are going to be paying more for healthcare in the future.”
13:30 Thinking about the actual Value Proposition to the consumer.
15:00 Who Innovation is targeted to.
16:20 Patient Acquisition, Patient Satisfaction, Patient Engagement.
16:50 New Innovations in Patient Engagement that Mark finds intriguing.
20:00 Looking at Care Coordination Technologies.
21:00 Connecting the Mission of Healthcare with the Business of Healthcare.
21: 15 Patient Experience as the Evaluation of Healthcare Business.
22:00 Navigating the many types of Healthcare Innovation Technologies.
22:30 “The first thing you have to look at is - do you understand it?”
24:15 Finding the Net Promoter score for Innovation Companies.
28:40 “In Healthcare today the word is ‘Collaboration’.”